Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBPF26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC729966 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRSF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBQLN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G3BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF462 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSTNP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPZA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WTH3DI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on